Searchable abstracts of presentations at key conferences in endocrinology

ea0022p846 | Thyroid | ECE2010

Limited therapeutically options in a case of invasive papillary thyroid carcinoma

Carsote Mara , Trifanescu Raluca , Chirita Corina , Ene Cristina , Ioachim Dumitru , Terzea Dana , Poiana Catalina , Coculescu Mihail

Introduction: Even the differentiated thyroid neoplasm have good prognostic, there are some particular cases that become very aggressive in short time, with poor management.Aim: We report a female case diagnosed with invasive papillary thyroid carcinoma.Case report: Seventy-three-year old female was diagnosed at age of 71 with a right lobe thyroid nodule (of almost 6 cm). At that moment the computed tomography (CT) of the cervical ...

ea0020p163 | Thyroid | ECE2009

Hashimoto’s thyroiditis: the value of antithyreoperoxidase antibodies measurement

Peretianu Dan , Carsote Mara , Samoila Ramona , Ene Cristina , Alexiu Florin , Poiana Catalina

Introduction: Hashimoto’s Thyroiditis is a part of the spectrum of thyroid autoimmune diseases. Even the proper diagnosis is obtained by pathological exam; usually the detection of high serum antithyroid antibodies is enough to diagnose the disorder. It also represents the most frequent cause of hypothyroidism in non-iodine deficient areas. Nevertheless the presence of the antithyroid antibodies does not always correlates with thyroid dysfunction.Ai...

ea0020p286 | Clinical case reports and clinical reports | ECE2009

Gasser ganglion as pituitary tumor – case report

Carsote Mara , Peretianu Dan , Gruia Adriana , Ene Cristina , Hortopan Dan , Poiana Catalina

Introduction: The Gasser Ganglion is a large semi lunar-shaped ganglion of the trigeminal nerve. It contains the cells of origin of the most sensory fibers of the fifth cranial nerve.Aim: Our purpose is to describe a case where Gasser ganglion has an anatomic variant (near the sella turcica), mimicking a hypophyseal tumor.Case presentation: Of 17 years female patient has a history of bradispaniomenorrhea (menses at 30–50 days)...

ea0020p326 | Clinical case reports and clinical reports | ECE2009

Cushing’s syndrome in a patient with bilateral adrenal masses and pituitary incidentaloma: case report

Poiana Catalina , Carsote Mara , Trifanescu Raluca , Hortopan Dan , Caragheorgheopol Andra , Samoila Ramona , Stanescu Bogdan

Introduction: Incidentaloma is a randomly discovered tumor with no apparent secretor activity. The term is mainly used for hypophysis and adrenals. There are relatively few situations where a patient has more than one such mass.Aim: To present the case of a patient with three tumors: a pituitary mass and bilateral adrenal masses, with clinical manifestations of Cushing’s syndrome.Case report: A 37-year-old female patient who h...

ea0003p120 | Endocrine Tumours and Neoplasia | BES2002

Expression of the F-box protein Skp-2 in normal and tumorous human pituitary

Musat M , Korbonits M , Pyle M , Gueorguiev M , Powell M , Dumitrache C , Poiana C , Grossman A

Disruption of the normal cell cycle is one of the most frequent alterations in tumour cells, contributing to uncontrolled cell proliferation during tumour development. The CDK inhibitor p27 plays a pivotal role in controlling cell proliferation during development and tumourigenesis, and has been implicated in tumorigenesis in rats. Previous studies have demonstrated changes in p27 protein expression, in human pituitary tumours,especially in corticotroph tumours, where p27 prot...

ea0056p181 | Bone ' Osteoporosis | ECE2018

PTH correlates with bone turnover serum markers in patients with end stage renal disease

Dusceac Roxana , Niculescu Dan Alexandru , Dragne Madalina Cristina , Dobre Ramona , David Cristiana , Tacu Cristian , Poiana Catalina

Background: End stage renal disease is usually associated with high serum parathyroid hormone (PTH) and increased bone turnover. The aim of our study was to correlate serum PTH with serum markers of bone turnover in patients with end stage renal disease (ESRD).Methods: We measured serum PTH, osteocalcin, procollagen type 1 n-terminal propeptide (P1NP) and beta-crosslaps in 64 (32 men) consecutive pacients, median (25, 75 percentile) age 61 (49.5, 65.5) y...

ea0056p734 | Endocrine tumours and neoplasia | ECE2018

Comparison of clinical and subclinical apoplexy in pituitary adenomas

Gheorghiu Monica Livia , Bouariu Alexandra , Trifanescu Raluca Alexandra , Poiana Catalina , Badiu Corin

Pituitary apoplexy is a rare syndrome due to a clinically overt hemorrhagic infarction, described in 2–7% of pituitary adenomas. A subclinical usually asymptomatic pituitary hemorrhage and/or infarction may be detected on routine imaging or during histopathological examination in 25–28% of patients with pituitary adenomas.Aim: We compared the clinical features and evolution of 166 patients with subclinical pituitary apoplexy (SPA) and 46 patien...

ea0056ep113 | Pituitary and Neuroendocrinology | ECE2018

Serum concentration of insulin-like growth factor I (IGF-I): reference values for adult Romanian population: Preliminary results

Alexandru Niculescu Dan , Dobre Ramona , Caragheorgheopol Andra , Popescu Nicoleta , Poiana Catalina

Background: Growth hormone, age, sex, genetics or nutrition status play an important role in insuline-like growth factor 1 (IGF-1) liver production and serum levels. Currently, there is no IGF-I reference range for Romanian population.Aim: To define sex- and age-adjusted reference values for serum IGF-I measured by an automated chemiluminescence immunoassay in adult Romanian population of healthy subjects.Methods: The study include...

ea0073pep1.4 | Presented ePosters 1: Adrenal and Cardiovascular Endocrinology | ECE2021

Adrenocortical oncocytoma in a patient with classic congenital adrenal hyperplasia

Baleanu Maria Cristina , Simona Andreea Găloiu , Popa Lavinia , Gherlan Iuliana , Dumitrascu Anda , Poiana Catalina

IntroductionOncocytic neoplasms arising in adrenal tissue are extremely rare with nearly 150 cases being reported in literature. They are mostly nonfunctioning benign tumors, incidentally discovered, but 20% of them demonstrate elements of malignancy and up to 30% appear to affect hormone production.Case reportA 35 years old female with primary amenorrhea, diagnosed with Congenital Adrenal Hyperplasia due to ...

ea0073aep482 | Pituitary and Neuroendocrinology | ECE2021

Factors that contribute to dopamine agonist resistance of prolactinomas

Berdeli Maria , Trifanescu Raluca , Caragheorgheopol Andra , Anda Dumitraşcu , Poiana Catalina

IntroductionProlactinomas are the most common hormone-secreting pituitary tumours encountered in the clinic. They are usually treated with dopamine agonists (DA): bromocriptine (BRC) and cabergoline (CAB), which are highly effective in the majority of cases. DA resistance is the failure to achieve normal levels of prolactin and, or reduction of the adenoma with at least 50%.Aimto assess the prevalence of the ...